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Background: Calcium phosphate cements (CPC) are low-temperature self-setting materials 
that have become widely used as synthetic bone grafts due to their excellent osteoconductive 
properties and similarity to the bone mineral phase (1). Nevertheless, their slow degradation 
in vivo (e.g. months up to years) delays the appearance of new bone (2). 
 
Aim: To investigate new routes for accelerating the resorption of these materials through their 
combination with collagen, and their processing as pre-set microspheres (MS). 
 
Material and Methods: The MS were prepared by water in oil emulsion. The CPC powder 
phase consisted of α-TCP which hydrolyses into hydroxyapatite. Water or a collagen solution 
was used as the liquid phase. Femoral condyles of female New Zealand white rabbits were 
used as animal model. Five 5 mm critical size defects were created and the MS were mixed 
with 1 ml of the animal’s blood to make a clot, implanting if afterwards in the defect. As a 
control, dense formulations of the same CPC compositions were prepared by mixing the liquid 
and the powder phase in situ to form a paste, injecting it afterwards in the defect. The animals 
were sacrificed at 1 and 3 months post-operative to analyse material resorption and bone 
formation by histology and scanning electron microscopy. 
 
Results: A significant increase of material resorption was found for the MS as compared to 
the dense CPC already after 1 month, although these became more evident at 3 months (Fig 
1 A, B). The amount of remaining biomaterial in the site of defect was around 75% and 69% 
for the dense CPC and collagen-CPC respectively, but was reduced to 35% and 20% for their 
respective MS formulations after 3 months. Furthermore, new tissue was able to grow within 
the implanted biomaterials, with ten times higher values for the MS compared to the dense 
CPC. Dense CPC allowed bone formation in the external perimeter of the material, and cell 
infiltration within the cracks (Fig 1 C), whereas the MS allowed higher cell infiltration 
throughout the whole defect site, showing perfect integration with the new bone formed 
without disrupting the trabecular structure (Fig 1D). 
 
 
 
 
 
 
 
Figure 1. Backscattered electron images of the dense collagen-CPC (A and C) and the 
collagen-CPC MS (B and D) after 3 months implantation. 
 
Conclusions: The results showed an enhanced MS resorption and accelerated bone 
formation that was even higher in the presence of collagen. The use of these MS as carriers 
A B C D 
for other biologically active molecules, enabled by their high microporosity and low-
temperature processing is under investigation. 
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